Neoadjuvant immunotherapy in non-small cell lung cancer: a narrative review on mechanisms, efficacy and safety

BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors and immunotherapy have been shown to improve survival rates, especially in non-small cell lung cancer (NSCLC) patients. More recently, several trials have evaluated the clinical roles of immunotherapy as neoadjuvant settings for NSCLC. There tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Lan, Lou, Guangyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562495/
https://www.ncbi.nlm.nih.gov/pubmed/36245597
http://dx.doi.org/10.21037/jtd-22-1192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562495/
https://www.ncbi.nlm.nih.gov/pubmed/36245597
http://dx.doi.org/10.21037/jtd-22-1192

Ejemplares similares